JPWO2020123795A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020123795A5
JPWO2020123795A5 JP2021533527A JP2021533527A JPWO2020123795A5 JP WO2020123795 A5 JPWO2020123795 A5 JP WO2020123795A5 JP 2021533527 A JP2021533527 A JP 2021533527A JP 2021533527 A JP2021533527 A JP 2021533527A JP WO2020123795 A5 JPWO2020123795 A5 JP WO2020123795A5
Authority
JP
Japan
Prior art keywords
nucleic acid
orf1
acid sequence
synthetic
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021533527A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513459A5 (https=
JP2022513459A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/065963 external-priority patent/WO2020123795A2/en
Publication of JP2022513459A publication Critical patent/JP2022513459A/ja
Publication of JP2022513459A5 publication Critical patent/JP2022513459A5/ja
Publication of JPWO2020123795A5 publication Critical patent/JPWO2020123795A5/ja
Priority to JP2024075364A priority Critical patent/JP2024099833A/ja
Withdrawn legal-status Critical Current

Links

JP2021533527A 2018-12-12 2019-12-12 タンパク質代替治療モダリティを送達するためのアネロソーム Withdrawn JP2022513459A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024075364A JP2024099833A (ja) 2018-12-12 2024-05-07 タンパク質代替治療モダリティを送達するためのアネロソーム

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862778866P 2018-12-12 2018-12-12
US201862778861P 2018-12-12 2018-12-12
US62/778,861 2018-12-12
US62/778,866 2018-12-12
PCT/US2019/065963 WO2020123795A2 (en) 2018-12-12 2019-12-12 Anellosomes for delivering protein replacement therapeutic modalities

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024075364A Division JP2024099833A (ja) 2018-12-12 2024-05-07 タンパク質代替治療モダリティを送達するためのアネロソーム

Publications (3)

Publication Number Publication Date
JP2022513459A JP2022513459A (ja) 2022-02-08
JP2022513459A5 JP2022513459A5 (https=) 2022-12-20
JPWO2020123795A5 true JPWO2020123795A5 (https=) 2022-12-20

Family

ID=69160356

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021533527A Withdrawn JP2022513459A (ja) 2018-12-12 2019-12-12 タンパク質代替治療モダリティを送達するためのアネロソーム
JP2024075364A Pending JP2024099833A (ja) 2018-12-12 2024-05-07 タンパク質代替治療モダリティを送達するためのアネロソーム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024075364A Pending JP2024099833A (ja) 2018-12-12 2024-05-07 タンパク質代替治療モダリティを送達するためのアネロソーム

Country Status (11)

Country Link
US (1) US20220073950A1 (https=)
EP (1) EP3894569A2 (https=)
JP (2) JP2022513459A (https=)
KR (1) KR20210125990A (https=)
CN (1) CN114127303A (https=)
AU (1) AU2019395418A1 (https=)
BR (1) BR112021010925A2 (https=)
CA (1) CA3119814A1 (https=)
IL (1) IL283781A (https=)
MX (1) MX2021006945A (https=)
WO (1) WO2020123795A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018256925B2 (en) 2017-04-28 2024-11-21 Agrospheres, Inc. Compositions and methods for the encapsulation and scalable delivery of agrochemicals
US11624061B2 (en) 2017-04-28 2023-04-11 Agrospheres, Inc. Compositions and methods for enzyme immobilization
BR112020005803A2 (pt) 2017-09-25 2020-12-01 Agrospheres, Inc. composições e métodos para produção e administração moduláveis de produtos biológicos
BR112021011124A2 (pt) * 2018-12-12 2022-03-15 Flagship Pioneering Innovations V Inc Anelossomos e métodos de uso
AU2021288320A1 (en) * 2020-06-12 2023-01-19 Flagship Pioneering Innovations V, Inc. Tandem anellovirus constructs
JP2023530451A (ja) * 2020-06-17 2023-07-18 フラッグシップ パイオニアリング イノベーションズ ブイ, インコーポレイテッド アネロウイルスを同定し及び特徴付ける方法並びにその使用
EP4267157A4 (en) * 2020-12-23 2025-05-07 Flagship Pioneering Innovations V, Inc. IN VITRO ASSEMBLY OF ANELLOVIRUS CAPSIDS WITH RNA
EP4415695A4 (en) * 2021-10-12 2025-11-26 Flagship Pioneering Innovations V Inc NEW ANELLOVECTOR COMPOSITIONS AND METHODS
US20250027107A1 (en) 2021-10-18 2025-01-23 Flagship Pioneering Innovations Vii, Llc Dna compositions and related methods
TW202529819A (zh) 2023-10-13 2025-08-01 美商旗艦先鋒創新公司 組織特異性指環載體(anellovector)遞送

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
US6395472B1 (en) * 1999-02-05 2002-05-28 Abbott Laboratories Methods of utilizing the TT virus
US9676828B2 (en) * 2010-06-23 2017-06-13 Deutsches Krebsforschungszentrum Rearranged TT virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
IL271275B1 (en) * 2017-06-13 2026-04-01 Flagship Pioneering Innovations V Inc Preparations containing croons and their uses
KR20210131309A (ko) * 2018-12-12 2021-11-02 플래그쉽 파이어니어링 이노베이션스 브이, 인크. 분비형 치료 양식을 운반하기 위한 아넬로좀
BR112021011124A2 (pt) * 2018-12-12 2022-03-15 Flagship Pioneering Innovations V Inc Anelossomos e métodos de uso
WO2020123753A2 (en) * 2018-12-12 2020-06-18 Flagship Pioneering Innovations V, Inc. Anellosomes for delivering intracellular therapeutic modalities

Similar Documents

Publication Publication Date Title
CN114736901B (zh) 用于减少pd-l1表达的寡核苷酸
CN112040988A (zh) 修饰的aav衣壳多肽用于治疗肌肉疾病
AU2019262225B2 (en) In vivo homology directed repair in heart, skeletal muscle, and muscle stem cells
WO2015196179A1 (en) Methods of packaging multiple adeno-associated virus vectors
KR20210131309A (ko) 분비형 치료 양식을 운반하기 위한 아넬로좀
KR20210125990A (ko) 단백질 대체 치료 양식을 운반하기 위한 아넬로좀
KR20210131310A (ko) 아넬로좀 및 사용 방법
JPWO2020123795A5 (https=)
TW202239762A (zh) 桿狀病毒表現系統
US20250064976A1 (en) Engineered pnma proteins and delivery systems thereof
JPWO2020123773A5 (https=)
KR20210044240A (ko) 재조합 핵산 구조물
JP2023548838A (ja) ニワトリ貧血ウイルス(cav)に基づくベクター
TW202223095A (zh) 串聯指環病毒構築體
Su et al. Identification of gene products suppressed by human immunodeficiency virus type 1 infection or gp120 exposure of primary human astrocytes by rapid subtraction hybridization
KR20230124682A (ko) Rna를 봉입하는 아넬로바이러스 캡시드의 시험관 내어셈블리
KR102842575B1 (ko) 유전자 및 단백질의 대량 카고를 인간 세포로 전달하기 위한 원핵-진핵 하이브리드 바이러스 벡터
US20250066815A1 (en) Engineered viral capsids with increased stability and methods of use thereof
JPWO2020123816A5 (https=)
JPWO2020123753A5 (https=)
US20240301372A1 (en) Treatment for hsv-1 using a meganuclease
WO2023081426A1 (en) Genome editing compositions and methods for treatment of friedreich's ataxia
WO2021067613A1 (en) Compositions and methods for treating amyotrophic lateral sclerosis
Bikou et al. Gene therapy for heart failure: status quo and quo vadis
JP2006515172A (ja) パラポックスウイルス・オヴィスの組換えタンパク質およびそれ由来の医薬組成物